Status:
RECRUITING
Pulmonary Vascular Disease and Cardiac Performance in Extreme Preterm Infants
Lead Sponsor:
McGill University Health Centre/Research Institute of the McGill University Health Centre
Conditions:
Prematurity; Extreme
Eligibility:
All Genders
7-5 years
Brief Summary
Pulmonary vascular disease and cardiac performance in extreme preterm infants: A prospective cross-sectional study
Detailed Description
The principal investigator hypothesize that premature newborns have disturbed cardiac performance and increased pulmonary pressures during neonatal life and at different pediatric ages. The principal...
Eligibility Criteria
Inclusion
- Infants born at \<29 weeks' gestational age admitted to the NICU
- All infants born at \<29 weeks' gestational age followed at MCH clinic after an admission in the NICU for prematurity \<29 weeks
Exclusion
- Congenital heart disease (except an atrial (ASD) or ventricular septal defect (VSD), or a patent ductus arteriosus (PDA))
- Congenital severe lung or airway malformation (choanal atresia, trachea-esophageal fistula or congenital pulmonary airway malformation)
- Genetic disorder (Trisomy 21).
Key Trial Info
Start Date :
October 12 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04114435
Start Date
October 12 2019
End Date
December 1 2025
Last Update
June 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mcgill University Health Centre
Montreal, Quebec, Canada, H4A 3J1